Sequencing of seven melanoma cell lines and donor-matched germline cells found MAP2K1 and MAP2K2 (MEK1 and MEK2, respectively) mutations, resulting in constitutive ERK phosphorylation and higher resistance to MEK inhibitors. This evidence concerns the gene MAP2K7 and melanoma.